Blog

Jessie Guo: G6PD is essential for KL but not KP lung tumorigenesis

Photo taken from Jessie Guo lab/X

Jul 14, 2024, 22:08

Jessie Guo: G6PD is essential for KL but not KP lung tumorigenesis

Jessie Guo, Associate Professor at Rutgers Cancer Institute of New Jersey, shared on X:

“Check out our new publication in Nature Communications. Our studies found that G6PD is essential for KL but not KP lung tumorigenesis. Thus, targeting G6PD could be a potential therapeutic strategy for tumors with KRAS and LKB1 co-mutations.

‘Glucose-6-phosphate dehydrogenase maintains redox homeostasis and biosynthesis in LKB1-deficient KRAS-driven lung cancer’

Authors: Taijin Lan, Sara Arastu, Jarrick Lam, Hyungsin Kim, Wenping Wang, Samuel Wang, Vrushank Bhatt, Eduardo Cararo Lopes, Zhixian Hu, Michael Sun, Xuefei Luo, Jonathan M. Ghergurovich, Xiaoyang Su, Joshua D. Rabinowitz, Eileen White, Jessie Yanxiang Guo.”

Source: Jessie Guo/X

cancer Eduardo Cararo Lopes Eileen White Hyungsin Kim Jarrick Lam Jessie Guo Jessie Yanxiang Guo Jonathan M. Ghergurovich Joshua D. Rabinowitz Michael Sun Nature Communications OncoDaily Oncology Samuel Wang Sara Arastu Taijin Lan Vrushank Bhatt Wenping Wang Xiaoyang Su Xuefei Luo Zhixian Hu

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage